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Abstract
Background: Palliative care (PC) is no longer offered with preference to cancer patients (CA), but also to patients
with non-malignant, progressive diseases. Taking current death statistics into account, PC in Europe will face a
growing number of patients dying from non-cancer diseases (NCA). More insights into specialized palliative home
care (SPHC) in NCAs are needed.
Methods: Retrospective analysis and group comparisons between CAs and NCAs of anonymous data of all patients
cared for between December 2009 and June 2012 by one SPHC team in Germany. Patient-, disease- and care-related
data are documented in clinical routine by specialized PC physicians and nurses in the Information System Palliative
Care 3.0 ® (ISPC®).
Results: Overall, 502 patients were cared for by the SPHC team; from 387 patients comprehensive data sets were
documented. These 387 data sets (CA: N = 300, 77.5 % and NCA: N = 87, 22.5 %) are used for further analysis here.
NCAs were significantly older (81 vs. 73 years; p < .001), than CAs and most often suffered from diseases of the nervous
system (40 %). They needed significantly more assistance with defecation (87 vs. 74 %; p < .001) and urination
(47 vs. 29 %; p < .001) and were more often affected from impaired vigilance (30 vs. 11 %; p < .001) than CAs. A by
trend higher proportion of NCAs died within one day after admission to palliative home care (12 vs. 5 %; p < .05) and a
smaller proportion was re-admitted to hospital during home care (6 vs. 20 %; p < .001). NCAs died predominantly in
nursing homes (50 vs. 20 %; p < .001).
Conclusions: Although the proportion of NCAs was relatively high in this study, the access to PC services seems to
takes place late in the disease trajectory, as demonstrated by the lower survival rate for NCAs. Nevertheless, the results
show, that NCAs PC needs are as complex and intense as in CAs.
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Background
During the last decades, hospice and PC has dynamically
evolved in Europe [1]. One central development in
Germany is the growing number of in- and outpatient pal-
liative and hospice care services [2]. Parallel to this, first
reimbursement models for inpatient and home PC have
emerged. Furthermore, palliative medicine now plays a
growing role in education for medical students, nurses
and other healthcare professionals.
The PC approach was primarily developed to support
incurable CA patients. Over the last decades, however,
there has been growing evidence that also patients with
non-malignant, progressive diseases are in need and may
benefit from PC [3–5]. This is underpinned by the fact
that all “patients […] facing the problem associated with
life-threatening illness” independent of their underlying
primary disease are included in the World Health
Organization’s (WHO’s) definition of PC [6]. However,
in Germany - as in many other countries - barriers to
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palliative and hospice care for NCA patients still exist
[7]. In fact the percentage of NCA patients receiving in-
patient PC, for example, is rising while the overall per-
centage, however, is still disproportionately low [8, 9].
Taking projections of statistics on death and current
findings into account, palliative and hospice care in
Europe will face a growing number of patients suffering
and dying from non-malignant diseases [10–12].
Despite this protracted evolution, palliative home care
for patients with NCA diseases is also increasingly
deserving of attention [13]. In 2007, a national bill passed
(§37b social security statutes book V), securing Germans
with life limiting advanced diseases and complex needs
the right to receive specialised PC at home [14]. Since then
regional specialised palliative home care services (SPHC)
have evolved throughout the country. The requirements for
SPHC providers are uniform concerning staffing, quality,
education and standards for adequate care provision. PC
teams are composed of physicians and nurses supported by
other professionals and therapists if necessary [15]. SPHC
teams treat patients in their own homes, in nursing homes
or hospices alongside (not replacing) their primary care
doctors and nursing services. SPHC support (24/7) includes
symptom control, counselling for patients and their rel-
atives, professional and informal caregivers, and general
practitioners, as well as organization, planning and co-
ordination of involved services, interventions in medical
or psycho-social crises, support in decision-making
procedures and management of ethical conflicts. All that
support is meant to enable patients to stay in their familiar
environment until death, if possible.
The involvement of SPHC can be prescribed by a
hospital physician or a practitioner. SPHC starts (almost)
always, if formally prescribed, for at least the first 7 days
and continues if the health insurance approves reimburse-
ment of the costs [16]. The necessity for SPHC has to be
re-evaluated on a regular basis. The main eligibility criteria
for the SPHC service are i) advanced progressive disease,
ii) at least two of seven complex symptom cluster (pain,
respiratory-cardiac, neurologic-psychiatric-psychological,
gastrointestinal, urogenital, ulcerated wounds or tumors,
others) and iii) a necessity for 24/7 on-call service, avoid-
ance for hospital readmission, expected crisis intervention
or symptom management. The SPHC service is fi-
nanced from a case compensation independent from
care expenses.
To date limited data are available regarding the daily
work of SPHC teams in Germany and, moreover, little
specific data on SPHC for terminally ill patients suffer-
ing from non-malignant diseases who may have differing
needs from CA patients receiving PC exist [5]. There are
only few studies and comments focussed on the treat-
ment of specific aspects [15] and the problems, chances
and expectations of general practitioners cooperating
with SPHC teams [16, 17]. One study on SPHC teams in
Bavaria has taken place in 2013 and allows for broader
information on organisation, performance and its effect
on patients and their relatives [18]. Therefore, this single
institution analysis investigates SPHC in Germany deliv-
ered for NCA and CA patients. Research on the access
to and utilization of PC services is highly important in
particular with respect to NCA patients who often have
similar symptoms and needs as CA patients but seem to
be underrepresented in PC services.
Study aim
The authors aim to answer the question whether terminally
ill patients suffering from non-malignant versus malignant
diseases receiving specialized palliative home care do have
comparable demographic characteristics and PC needs or
whether they form different patient populations.
Methods
Study setting
As a well-established regional team, the SPHC Fürth
(Bavaria) was approached to cooperate for this study.
The team started in 2009 and consists of six physicians
and seven nurses working both in part or full time. All
physicians of this single service regularly work in their
private practice as family physicians or specialists and
provide an on-call service for this SPHC team. The
nurses work for the SPHC team around the clock. All
team members are planned and organized so that each
group of two physicians and nurses are available during
the daytime from 08.00 a.m. until 20.00 p.m.. During the
night between 20.00 p.m. and 08.00 a.m., a single physician
and a nurse perform on-call duty.
Data sets and study variables
Since its establishment in 2009, patient-, disease- and
care-related data such as gender, age, marital status,
living situation, residential area (urban vs. rural), primary
diagnosis, nursing care level, advance directive, symp-
toms and problems and characteristics, number of visits
and duration of SPHC, re-admittance to hospital and
place of death are documented by specialized PC physi-
cians and nurses.
Symptoms were assessed via a symptom- and prob-
lem checklist analogue to symptom- and problem
checklist from the Hospice and Palliative care Evaluation
(HOPE) [16] and were scaled as follows: 0 = none, 1 =mild,
2 =moderate, 3 = severe. Additional nursing care problems
such as need for assistance with defecation and bladder
function or deterioration of vigilance were added in the
documentation of the SPHC team.
For data management, the Information System Palliative
Care 3.0 ® (ISPC®), developed by Smart-Q Softwaresysteme
GmbH, was used. The ISPC® database was adapted
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continuously during the first years according to the
professionals’ documentation needs. As a result, some
additional information relevant for their daily clinical
practice was integrated into the initial database, so that
several items were not documented during the whole
period of the study analysis chosen here.
For this investigation, datasets from ISPC® were extracted
to Microsoft Excel 2010 and tested for plausibility. Detected
coding inconsistencies and missing data were checked and
validated in the original, electronic ISPC® patient chart and
added to the electronic database.
For this analysis no additional data collection, patient in-
volvement or study measures took place. The study was ap-
proved by the local Ethics Committee (Ethik-Kommission
der Friedrich-Alexander- Universität Erlangen-Nürnberg).
After careful consideration of the selected study method of
a retrospective data analysis, the ethics committee con-
firmed that no written informed consent had to be obtained
from the patients and waived the requirement for informed
consent before study application.
Data analyses and statistics
This retrospective analysis used fully anonymous data of all
patients cared for between December 2009 and June 2012.
SPHC team members entered the data into ISPC®, an on-
going data basis used for clinical routine practice, and a
medical student finally extracted these data to SPSS.
The program IBM SPSS Statistics 21.0 (IBM Corporation,
1 New Orchard Road, Armonk, New York, United States)
for Windows was applied for statistical analysis. Descriptive
analysis of the data was performed.
To further investigate group differences between CA vs.
NCA patients, T-Test in ratio or interval scaled variables
or Chi2-Tests and Fisher’s Exact Tests for low given N
in nominal or ordinal data in 2x2 contingence tables
(two-tailed p < 0.01) were calculated. Additionally, logistic
regression analyses were performed to test whether group
differences in patient age between the NCA and CA group
could explain other group differences.
Results
Study sample
Between December 2009 and June 2012, 502 patients were
cared for by the SPHC team. Due to the formation and
foundation of the SPHC team, in the beginning of their
work documentation was based on non-systematic hand-
written notes. The chronological first 115 data sets were
not suitable for any data analysis and were therefore
excluded. The development of a systematic documenta-
tion system became work-in-progress in the following
time. More comprehensive and systematic data are avail-
able from 387 patients between October 2010 and June
2012 and were used here for further analysis. Due to the
very low validity and range of data of the first 115 data sets,
no comparison of patient characteristics between the data
sets that were used and the excluded data sets was possible.
The remaining 387 data sets include two independent sub-
groups of CA (N = 300, 77.5 %) and NCA (N = 87,
22.5 %) patients and are used for further analysis here.
Demographic data
NCAs were tested significantly older (81 ± 10 years) than
CAs (73 ± 12 years) with an almost equal proportion of
female gender (58 vs. 55 %). Considering the individual
marital status, NCA patients were significantly less often
married (25 vs. 48 %), but more often widowed (38 vs.
23 %) than CA patients. According to this finding, NCA
patients were living less often with relatives (30 vs. 53 %)
or alone (7 vs. 18 %), but more often in nursing homes
(55 vs. 22 %). (see Table 1). The significant group differ-
ence in marital status is controlled by the patients’ age
in logistic regression (p = .165).
At the time of admission into SPHC care, NCA patients
primarily wished to experience relief from suffering and
symptom management (85 %), no re-admission to hospital
(43 %), to stay at home (28 %) or to gain more physical
power (9 %). There was no statistically significant differ-
ence to treatment goals documented for CA patients.
Table 1 Group differences between non-cancer (N= 87) vs. cancer














58 % 55 % p = .714
Marital status Married 22 (25 %) 143 (48 %) p < .001
Widowed 33 (38 %) 69 (23 %)
Divorced 6 (7 %) 19 (6 %)
Single 2 (2 %) 16 (5 %)
Missing
Data





26 (30 %) 160 (53 %) p < .001
Alone 6 (7 %) 54 (18 %)
Nursing
Home
48 (55 %) 67 (22 %)
Hospice 0 (0 %) 8 (3 %)
Missing
Data
7 (8 %) 11 (4 %)
Residential
area
Urban 41 (47 %) 156 (52 %) p = .466
Rural 46 (53 %) 144 (48 %)
Advance directive 36 (41 %) 145 (48 %) p = .274
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Disease-related data
Patients with non-malignant illnesses most often suf-
fered from diseases of the nervous (40 %), circulatory
(18 %), genitourinary or respiratory (each 14 %) system
(see Table 2).
The most frequent NCA illnesses were dementia
(18 %), liver cirrhosis (8 %) and multiple acute stroke
syndrome (7 %).
NCA patients experienced by trend more often moderate
or severe intensities of neurologic, psychiatric or psycho-
logical symptoms and problems (15 vs. 8 %), were in signifi-
cantly higher need for assistance with defecation (87 vs.
74 %) and bladder function (47 vs. 29 %) and suffered con-
siderably more often from moderate to severe deterioration
of vigilance (somnolent or comatose) (30 vs. 11 %) as esti-
mated in a symptom and problem checklist by profes-
sionals of the SPHC team (see Table 3).
General patients’ condition and care-related data
At the time of admission to SPHC, significantly more
NCA patients were classified to nursing care levels de-
pending on individual needs for nursing support (61 vs.
31 %) as defined by the Medical Service of the Health
Funds (Medizinischer Dienst der Krankenkassen, MDK)
than CA patients.1 The main focus of support for the
NCA patients was significantly more coordination of
care (14 vs. 4 %) or counselling (15 vs. 2 %), but signifi-
cantly less often partial care (e.g. in addition to nursing
services, family physician etc.) (56 vs. 72 %) or complete
care (full home care without involvement of other ser-
vices) (13 vs. 20 %).
The mean number of face-to-face contacts to NCA
patients was significantly lower (8 vs. 11 times) and the
mean duration of care shorter (27 ± 53 vs. 31 ± 43 days;
p = .454) than in CA patients. The percentage of NCA
patients who died within the first 24 h after inclusion
into SPHC was higher (12 vs. 5 %) than in CA patients.
Less NCA than CA patients were re-admitted to hospital
(6 vs. 20 %). The significant group differences in propor-
tion of re-admittance is controlled by the patients’ age
in logistic regression (p = .071). Significantly more NCA
patients died in nursing homes (50 vs. 20 %), but less
in private homes (30 vs. 55 %) than CA patients (see
Table 4).
A higher proportion of NCA patients (20 vs. 10 %)
was discharged from SPHC care.
Discussion
In Germany little is known about specialized PC at
home for terminally ill patients suffering from non-
malignant diseases. To the best of our knowledge, this is
the first study comparing SPHC care for terminally ill
NCA to CA patients. The central findings from this in-
vestigation point at disadvantageous differences of NCAs
versus CAs regarding age, marital status and living situ-
ation, nursing care needs and restricted abilities for
everyday life, the type of SPHC offered, re-admittance to
hospital and place of death which is comparable to inter-
national research results [19].
The study subject shows the importance of taking into
account the specific needs and characteristics of patients
with NCA diseases in specialized palliative home care.
Table 2 Primary non-cancer diagnosis (N = 87)
Primary non-cancer diagnosis ICD-10 Percentage
Diseases of the Nervous system





(e. g. Heart Failure)
I00-I99 16 (19 %)
Genitourinary system
(e. g. UTI sepsis)
N00-N99 12 (14 %)
Respiratory system
(e. g. COPD)
J00-J99 12 (14 %)
Digestive system
(e. g. Liver Cirrhosis)
K00-K93 9 (10 %)
Musculoskeletal system
(e. g. Osteopathy)
M00-M99 2 (2 %)
Infectious and parasitic diseases
(e. g. HIV)
A00-B99 1 (1 %)
Overall 87 (100 %)
Table 3 Group differences between non-cancer (N = 87) vs.
cancer patients (N = 300) in percentage of patients suffering
from moderate/severe intensities of certain symptoms and
problems






Pain 10 (12 %) 35 (12 %) p = 1.00
Respiratory, cardiac 10 (12 %) 22 (7 %) p = .246
Neurologic, psychiatric,
psychological
13 (15 %) 24 (8 %) p = .049
Gastrointestinal 7 (8 %) 33 (11 %) p = .529
Urogenital 4 (5 %) 15 (5 %) p = 1.00
Ulcerated wounds/ tumours 3 (3 %) 6 (2 %) p = .419




41 (47 %) 88 (29 %) p = .001
Deterioration of vigilance
(somnolent/comatose)
26 (30 %) 34 (11 %) p = .001
Social situation 8 (9 %) 16 (5 %) p = .192
Ethical conflicts 5 (6 %) 15 (5 %) p = .779
Problems in social law
issues
3 (3 %) 8 (3 %) p = .711
Burden of social support
system
7 (8 %) 30 (10 %) p = .670
Existential crisis 5 (6 %) 12 (4 %) p = .542
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Beside the distinction between CA and NCA patients, the
results underline the influence of individual parameters
such as the patient’s age, family status, living situation,
symptoms and problems and time of access to SPHC.
The results of the investigation presented here show that
end-of-life needs for PC in NCs are at least as complex and
intense as they are in CAs [20]. The need for nursing assist-
ance, medical equipment and the burden with symptoms
are at a comparable level with CAs. The authors conclude
that the integration of palliative home care takes place ra-
ther late in the disease trajectory of both NCAs and CAs as
seen in the very short survival time for a considerable part
of both patient groups. Therefore, the expansion of special-
ized PC structures and opportunities which meet the spe-
cial needs of NCAs is urgently needed.
In both patient groups, the overall number of patients
who were re-admitted to hospital was low. This may, on
the one hand, be due to the frequent patient wishes to
avoid re-admittance to hospital and to remain at home. On
the other hand, these goals may also be encouraged by pol-
icy makers and health care insurances who intended SPHC
teams to keep patients stable at home, while saving costs
on expensive, long-term hospital stays [1, 12].
In Germany the access for NCA patients to palliative
home care is still hampered. Two main reasons may be
mentioned here. The national report of an evaluation of
the permission of PC activities by German health care
insurances shows that the coverage of costs for specia-
lised home care PC was denied especially (I) if patients
were privately insured or (II) were suffering from a non-
malignant disease [6]. This hypothesis is reinforced by
the fact that a higher proportion of NCA patients is, fol-
lowing primary inclusion, again discharged alive from
SPHC, perhaps due to possible retraction of consent for
reimbursement by their health care insurance. These as-
pects may at least in part help explain why we have not
reached an equal distribution of diagnosis groups in pal-
liative and hospice care services although this 50:50
Table 4 Group differences between non-cancer (N = 87) vs. cancer patients (N = 300) in care-related information (significance level






Nursing care level (need in assistance with body care, feeding,
mobilization and housing)
None 33 (38 %) 201 (67 %) p < .001
1: 1.5 h per day 16 (18 %) 54 (18 %)
2: at least 3 h per day 19 (22 %) 31 (10 %)
3: at least 5 h per day 18 (21 %) 8 (3 %)
Missing Data 1 (1 %) 6 (2 %)
Type of SPHC Partial Care 49 (56 %) 215 (72 %) p < .001
Complete Care 11 (13 %) 61 (20 %)
Coordination 12 (14 %) 11 (4 %)
Counselling 13 (15 %) 6 (2 %)
Missing Data 2 (2 %) 7 (2 %)
Number of involved professional caregiver 1.2 ± 0.4 1.4 ± 0.6 p = .068
Number of general medical equipment provided (e.g. wheel chair) 3.4 ± 2.0 2.9 ± 1.8 p = .084
Duration of SPHC 27 ± 53 days 31 ± 43 days p = .454
Number of SPHC visits 8 ± 8 visits 11 ± 9 visits p = .011
Death < 1 day 10 (12 %) 15 (5 %) p = .044
Re-admittance to hospital 6 (6 %) 60 (20 %) p < .001
1.3 ± 0.5 times 1.5 ± 1.4 times p = .723
11 ± 8 days 11 ± 13 days p = .889
End of SPHC Discharge from SPHC 17 (20 %) 31 (10 %) p = .027
Death 70 (80 %) 269 (90 %)
Place of death N = 339 (70/269) At Home 21 (30 %) 149 (55 %) p < .001
Nursing Home 35 (50 %) 53 (20 %)
Hospice 10 (15 %) 44 (16 %)
Hospital 2 (3 %) 18 (7 %)
Other Institutions 1 (1 %) 1 (0 %)
Missing Data 1 (1 %) 4 (2 %)
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distribution is expected for Europe in the upcoming
years. Several barriers and challenges why non-cancer
patients are under-represented on the caseloads of com-
munity Macmillan specialist palliative care nurses were
also reported by Andrews and colleagues (2011). The au-
thors argue that especially the viewpoints of patients and
carers should be considered and new innovative models
of service delivery be developed [21].
The local situation found in our study is congruent to
the development in other countries such as the UK. For
the UK the National Survey of Patient Activity Data for
Specialist Palliative Care Services from 2010–2011 sum-
marizes that there, as well, only 21 % of all home care
patients had a primary NCA diagnosis [22], with a simi-
lar distribution for circulatory, respiratory and neuro-
logical diseases.
Steps in the right direction have been made and positive
trends can be seen in the development of PC internationally
[23], but still a lot of work and initiatives are needed to in-
fluence policy and develop adequate long-term financing
structures for NCA patients with PC needs [24].
Study limitations
Due to the study design of a retrospective data analysis,
only routine data from clinical practice were investigated
here. Therefore, the results have to be interpreted cau-
tiously. The analysis has a strongly explorative and de-
scriptive character due to the novelty of the service
implementation and provides only basic data. In addition,
the subgroup of NCA and CA are heterogeneous in itself
and include different primary diseases which may have
contributed to differences in needs and symptoms. Future
research should conduct a prospective study including the
involvement of the patients themselves in data collection.
Due to changes in documentation patterns, systems
and items during the investigated period, a considerable
percentage of missing data in several variables occurred.
No validated symptom assessment tool was used, hence
limiting, to a certain extent, the value of data on symp-
toms and problems.
As SPHC teams in Germany are individually organized
and structured, they are free and differ in their docu-
mentation routines and priorities, so that the findings of
a single service is not representative and therefore can-
not be generalized to other regions, SPHC teams and pa-
tient groups.
Conclusions
Main findings indicate that the proportion of NCA
patients among all patients receiving SPHC was high in
the investigated single service, but in accordance to an
overall assessments of SPHC in Bavaria and therefore
rather representative [18]. They have severe PC needs
but relatively late access to PC services.
Although more and more patients suffering from non-
malignant diseases are equally in need of specialist PC as
CA patients and are slowly getting access to PC and
hospice services, financing models are still not adequate.
More political developments are needed to fill this gap.
Endnotes
1In Germany, an application to determine the need for
nursing care for a certain patient is made to the Medical
Service of the Health Funds (MDK). This application is
followed by a face-to-face meeting between the certain
patient and an employee of the MDK. This employee is
authorized to evaluate the individual need for nursing
care e.g. in body care, mobility, management of one’s
own household. The need for nursing care in these tasks
corresponds to defined time units. The sum of all time
units then results in a proposal of the employee for a
nursing care level to the Health Funds.
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